Evidence map›Paper›PMID 36221035›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2022

Systematic translation and adaptation of the FOCUS program, a USA-based supportive intervention for persons with cancer and their family caregivers, for use in six European countries.

Maaike van der Wel, Doris van der Smissen, Sigrid Dierickx, Joachim Cohen, Peter Hudson, Aline De Vleminck, Lydia Tutt, David Scott, Silvia Di Leo, Caroline Moeller Arnfeldt and 5 more

Open access · hybridAbstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 9 institutions in 8 countries.

Maaike van der WelErasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands. m.vanderwel.1@erasmusmc.nl.
Doris van der SmissenErasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Sigrid DierickxEnd-of-Life Care Research Group, Ghent University and Vrije Universiteit Brussel, Ghent, Belgium.
Joachim CohenEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium.
Peter HudsonEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium.
Aline De VleminckEnd-of-Life Care Research Group, Vrije Universiteit Brussel (VUB) & Ghent University, Brussels, Belgium.
Lydia TuttCicely Saunders Institute of Palliative Care, Policy and Rehabilitation, King's College London, London, UK.
David ScottSchool of Nursing and Midwifery, The Queen's University of Belfast, Belfast, UK.
Silvia Di LeoHealth Professions Department, Azienda USL-IRCCS Di Reggio Emilia, Reggio Emilia, Italy.
Caroline Moeller ArnfeldtDepartment of Public Health, University of Copenhagen, Copenhagen, Denmark.
Catherine JordanUniversity College Dublin, National University of Ireland, Dublin, Ireland.
Laurel NorthouseSchool of Nursing, University of Michigan, Ann Arbor, MI, USA.
Judith RietjensErasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Agnes van der HeideErasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Erica WitkampErasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands.
Erasmus MC · NLVrije Universiteit Brussel · BECicely Saunders International · GBGhent University · BEIstituti di Ricovero e Cura a Carattere Scientifico · ITNational University of Ireland · IEQueen's University Belfast · GBUniversity of Copenhagen · DKUniversity of Michigan–Ann Arbor · US

Funding

European Union's Horizon 2020 research and innovation program 825722HSC R&D Division, Public Health Agengy Northern Ireland COM/5599/20
6 · The paper itself

Abstract

purposeHaving advanced cancer presents many challenges for patients and family caregivers. The FOCUS program is a psychoeducational nurse-led intervention, developed in the USA, to support dyads of patients with cancer and their family caregivers to live with the illness. The program includes a conversation manual and information resources for dyads. We aimed to develop a version of the program for dyads facing advanced cancer in six European countries.

methodThe Participatory and Iterative Process Framework for Language Adaptation (PIPFLA) was used to guide the translation of the program to the local contexts of Belgium, Denmark, Ireland, Italy, the Netherlands, and the UK. In several rounds, potential program users (e.g., nurses, clinicians, patients, family caregivers) and researchers from all six countries reviewed program materials and advised on adaptations.

resultsThe PIPFLA process resulted in one European version of the program in different languages (FOCUS +). The FOCUS + conversation manual is uniform across all countries. The main adaptations included additional attention to both family caregiver and patient needs; more emphasis on self-management, advance care planning, and shared responsibilities; discussing the dyad's outlook rather than optimism; addressing the role of nurses as educational rather than therapeutic; and more suggestions to refer dyads to health care professionals for specific care needs. The information resources for dyads were adapted to fit with local contexts.

conclusionThe PIPFLA methodology is an efficient and effective framework to thoroughly translate and culturally adapt a complex USA-based program for use in six European countries in collaboration with end users.

Indexed as

Advance Care PlanningNeoplasmsCaregiversCommunicationHumansTranslationsAdvanced cancerFamily caregiverInterventionPIPFLASupportive careTranslation and adaptation

Identifiers

PMID36221035
PMCPMC9715502
OpenAlexW4304588230

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.